Evidence map›Paper›PMID 38426763›Full record

ArticleEuropean heart journal. Cardiovascular Imaging2024

Association between subclinical atherosclerosis burden and unrecognized myocardial infarction detected by cardiac magnetic resonance in middle-aged low-risk adults.

Leticia Fernández-Friera, Ana García-Alvarez, Belen Oliva, Inés García-Lunar, Iris García, Andrea Moreno-Arciniegas, Sandra Gómez-Talavera, Cristina Pérez-Herreras, Javier Sánchez-González, Vicente Martinez de Vega and 6 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in European heart journal. Cardiovascular Imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01410318 (Early Detection and Progression of Subclinical Atherosclerosis and Its Relationship to Coronary Risk Factors), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01410318 active not recruitingnot on this map

Early Detection and Progression of Subclinical Atherosclerosis and Its Relationship to Coronary Risk Factors

TypeobservationalSponsorFundación Centro Nacional de Investigaciones Cardiovasculares Carlos IIIRan2010 to 2030Enrolled4,184ConditionsAtherosclerosis
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Leticia Fernández-FrieraCentro Nacional de Investigaciones Cardiovasculares (CNIC), Melchor Fernández Almagro 3, 28029, Madrid, Spain.
Ana García-AlvarezCentro Nacional de Investigaciones Cardiovasculares (CNIC), Melchor Fernández Almagro 3, 28029, Madrid, Spain.
Belen OlivaCentro Nacional de Investigaciones Cardiovasculares (CNIC), Melchor Fernández Almagro 3, 28029, Madrid, Spain.
Inés García-LunarCentro Nacional de Investigaciones Cardiovasculares (CNIC), Melchor Fernández Almagro 3, 28029, Madrid, Spain.
Iris GarcíaCentro Nacional de Investigaciones Cardiovasculares (CNIC), Melchor Fernández Almagro 3, 28029, Madrid, Spain.
Andrea Moreno-ArciniegasCentro Nacional de Investigaciones Cardiovasculares (CNIC), Melchor Fernández Almagro 3, 28029, Madrid, Spain.
Sandra Gómez-TalaveraCentro Nacional de Investigaciones Cardiovasculares (CNIC), Melchor Fernández Almagro 3, 28029, Madrid, Spain.
Cristina Pérez-HerrerasBanco de Santander, Madrid, Spain.
Javier Sánchez-GonzálezPhilips Healthcare Iberia, Spain.
Vicente Martinez de VegaCardiology Department, Hospital Universitario Quirón, Madrid, Spain.
Xavier RosselloCentro Nacional de Investigaciones Cardiovasculares (CNIC), Melchor Fernández Almagro 3, 28029, Madrid, Spain.
Héctor BuenoCentro Nacional de Investigaciones Cardiovasculares (CNIC), Melchor Fernández Almagro 3, 28029, Madrid, Spain.
Antonio Fernández-OrtizCentro Nacional de Investigaciones Cardiovasculares (CNIC), Melchor Fernández Almagro 3, 28029, Madrid, Spain.ORCID 0000-0002-3239-1910
Borja IbañezCentro Nacional de Investigaciones Cardiovasculares (CNIC), Melchor Fernández Almagro 3, 28029, Madrid, Spain.
Javier SanzCentro Nacional de Investigaciones Cardiovasculares (CNIC), Melchor Fernández Almagro 3, 28029, Madrid, Spain.
Valentín FusterCentro Nacional de Investigaciones Cardiovasculares (CNIC), Melchor Fernández Almagro 3, 28029, Madrid, Spain.
Spanish National Centre for Cardiovascular Research · ESBanco Santander (Spain) · ESHospital Universitario Quirónsalud Madrid · ESPhilips (Spain) · ES

Funding

Centro Nacional de Investigaciones CardiovascularesEuropean Regional Development FundInstituto de Salud Carlos IIIMinisterio de Ciencia e InnovaciónPro CNIC FoundationSevero Ochoa Center of Excellence CEX2020-001041-S
6 · The paper itself

Abstract

aimsEvidence on the association between subclinical atherosclerosis (SA) and cardiovascular (CV) events in low-risk populations is scant. To study the association between SA burden and an ischaemic scar (IS), identified by cardiac magnetic resonance (CMR), as a surrogate of CV endpoint, in a low-risk population. METHODS AND

resultsA cohort of 712 asymptomatic middle-aged individuals from the Progression of Early SA (PESA-CNIC-Santander) study (median age 51 years, 84% male, median SCORE2 3.37) were evaluated on enrolment and at 3-year follow-up with 2D/3D vascular ultrasound (VUS) and coronary artery calcification scoring (CACS). A cardiac magnetic study (CMR) was subsequently performed and IS defined as the presence of subendocardial or transmural late gadolinium enhancement (LGE). On CMR, 132 (19.1%) participants had positive LGE, and IS was identified in 20 (2.9%) participants. Individuals with IS had significantly higher SCORE2 at baseline and higher CACS and peripheral SA burden (number of plaques by 2DVUS and plaque volume by 3DVUS) at both SA evaluations. High CACS and peripheral SA (number of plaques) burden were independently associated with the presence of IS, after adjusting for SCORE2 [OR for 3rd tertile, 8.31; 95% confidence interval (CI) 2.85-24.2; P < 0.001; and 2.77; 95% CI, 1.02-7.51; P = 0.045, respectively] and provided significant incremental diagnostic value over SCORE2.

conclusionIn a low-risk middle-aged population, SA burden (CAC and peripheral plaques) was independently associated with a higher prevalence of IS identified by CMR. These findings reinforce the value of SA evaluation to early implement preventive measures. CLINICAL

trial registrationProgression of Early Subclinical Atherosclerosis (PESA) Study Identifier: NCT01410318.

Indexed as

Magnetic Resonance Imaging, CineMyocardial InfarctionAdultAsymptomatic DiseasesAtherosclerosisCohort StudiesCoronary Artery DiseaseFemaleHumansMaleMiddle AgedProspective StudiesRisk Assessmentcardiac magnetic resonanceischaemic scarsubclinical atherosclerosis

Identifiers

PMID38426763
PMCPMC11210973
OpenAlexW4392344388

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.